Rachael Louise Slater

2PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 16, 2020
The cost effectiveness of pembrolizumab versus chemotherapy or atezolizumab as second-line therapy for advanced urothelial carcinoma in the United States.

Rachael Louise Slater, Yizhen Lai, Yichen Zhong

|Oct 07, 2019
Modelling Survival of Patients Treated with Adjuvant Nivolumab Who Have Melanoma with Lymph Node Involvement or Metastatic Disease After Complete Resection.

Rachael Batteson, Rose Hart, Matthew Hemstock

Pageof 1

Frequent Collaborators

1 joint publications

Yang Meng